Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Han, Jiyou | - |
dc.contributor.author | Won, Miae | - |
dc.contributor.author | Kim, Ji Hyeon | - |
dc.contributor.author | Jung, Eugeine | - |
dc.contributor.author | Min, Kyungim | - |
dc.contributor.author | Jangili, Paramesh | - |
dc.contributor.author | Kim, Jong Seung | - |
dc.date.accessioned | 2021-08-30T08:15:04Z | - |
dc.date.available | 2021-08-30T08:15:04Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-11-21 | - |
dc.identifier.issn | 0306-0012 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/51470 | - |
dc.description.abstract | Cancer stem cells (CSCs), also called tumor-initiating cells (TICs), have been studied intensively due to their rapid proliferation, migration, and role in the recurrence of cancer. In general, CSC marker-positive cells [CD133, CD44, CD166, aldehyde dehydrogenase (ALDH), and epithelial cell adhesion molecule (EpCAM)] exhibit a 100-fold increased capacity to initiate cancer. Within a heterogeneous tumor mass, only approximately 0.05-3% of cells are suspected to be CSCs and able to proliferate under hypoxia. Interestingly, CSCs, cancer cells, and normal stem cells share many cytochemical properties, such as inhibition of the redox system for reactive oxygen species (ROS) production and high expression of drug resistance transporters. However, compared to normal stem cells, CSCs develop unique metabolic flexibility, which involves switching between oxidative phosphorylation (OXPHOS) and glycolysis as their main source of energy. Due to the similarities between CSCs and other cancer cells and normal stem cells, limited chemotherapeutic and bio-imaging reagents specific for CSCs have been developed. In this short review, we address the current knowledge regarding CSCs with a focus on designing chemotherapeutic and bio-imaging reagents that target CSCs. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.subject | FLUORESCENT-PROBE | - |
dc.subject | THERAPY | - |
dc.subject | IDENTIFICATION | - |
dc.subject | APTAMER | - |
dc.title | Cancer stem cell-targeted bio-imaging and chemotherapeutic perspective | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Won, Miae | - |
dc.contributor.affiliatedAuthor | Kim, Jong Seung | - |
dc.identifier.doi | 10.1039/d0cs00379d | - |
dc.identifier.scopusid | 2-s2.0-85092698632 | - |
dc.identifier.wosid | 000590395000016 | - |
dc.identifier.bibliographicCitation | CHEMICAL SOCIETY REVIEWS, v.49, no.22, pp.7856 - 7878 | - |
dc.relation.isPartOf | CHEMICAL SOCIETY REVIEWS | - |
dc.citation.title | CHEMICAL SOCIETY REVIEWS | - |
dc.citation.volume | 49 | - |
dc.citation.number | 22 | - |
dc.citation.startPage | 7856 | - |
dc.citation.endPage | 7878 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | FLUORESCENT-PROBE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | APTAMER | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.